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Prevalence and Risk Factors for Development of Hemorrhagic Gastro-Intestinal Disease in Veterinary 1 
Intensive Care Units in the United Kingdom 2 
 3 
Abstract 4 
Objective: To determine the prevalence of hemorrhagic gastro-intestinal (GI) disease developing in dogs 5 
and cats admitted for management of non-GI disease in veterinary intensive care units (ICUs). 6 
Design: Retrospective study of animals presented between October 2012 and July 2013. 7 
Setting: Three ICUs located in veterinary teaching hospitals in the United Kingdom. 8 
Animals: Dogs (n=272) and cats (n=94) were consecutively enrolled from three ICUs if they were 9 
hospitalized in the unit for at least twenty-four hours.  Cases were excluded if they had hemorrhagic GI 10 
disease in the forty-eight hour period before presentation or in the twenty-four hour period after 11 
admission.  Cases were also excluded if they suffered skull fracture, epistaxis or hemoptysis, if they 12 
underwent surgical procedures of the GI or upper respiratory tracts, or if they were presented for 13 
management of GI disease. 14 
Measurements and Main Results: Hemorhagic GI disease was observed in dogs at all three units, but at 15 
different rates (Center 1: 10.3%, Center 2: 4.8%, Center 3: 2.2%).  Hemorrhagic GI disease was not 16 
observed in cats at any of the participating centers.  Construction of a multivariable logistic regression 17 
model revealed that serum albumin concentration, administration of prophylactic gastro-protectant drugs 18 
and institution were significantly associated with the development of hemorrhagic GI disease in dogs.  19 
Development of hemorrhagic GI disease and placement of a feeding tube were significantly associated 20 
with mortality during the period of hospitalization in dogs.  Thirty-seven (13.6%) dogs and 12 (12.8%) 21 
cats died or were euthanized while hospitalized, with a higher mortality rate (42.1%) in dogs with 22 
hemorrhagic GI disease.    23 
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Conclusions: Hemorrhagic GI disease does develop in dogs hospitalized for management of non-GI 24 
disease, but this phenomenon was not observed in cats.  Development of hemorrhagic GI disease 25 
appeared to have a significant impact on survival in veterinary ICUs. 26 
 27 
Keywords: Stress-related mucosal disease, stress ulcer prophylaxis, omeprazole, enteral feeding 28 
 29 
Abbreviations: GI: gastro-intestinal; GMB: gastric mucosal barrier; ICU: intensive care unit; MODS: 30 
multiple organ dysfunction syndrome; NSAID: non-steroidal anti-inflammatory drug; ROC: receiver 31 
operator characteristic; SIRS: systemic inflammatory response syndrome; SRMD: stress-related mucosal 32 
disease 33 
 34 
 35 
Introduction 36 
In human medicine, stress-related mucosal disease (SRMD) refers to the development of erosive 37 
lesions of the stomach and intestines in patients admitted to ICUs for management of severe illness
1
.  The 38 
term covers a spectrum of disease, from superficial mucosal injury detectable only by 39 
gastroduodenoscopy to severe ulceration that results in clinically important hemorrhage.  Overt clinical 40 
bleeding due to SRMD was reported to occur in approximately 4% of humans admitted to a group of 41 
ICUs in Canada
2
, and development of this disease significantly increased the risk of death during the 42 
period of hospitalization. 43 
 44 
Impaired perfusion of the gastric mucosal barrier (GMB) is the proximate cause of SRMD, but 45 
development of the disease is reflective of systemic changes in hemodynamic status and inflammatory 46 
cascade
3
.  Splanchnic hypoperfusion caused by sympathetic stimulation or hypovolemia is likely to be an 47 
important factor in the development of SRMD but it may be difficult to detect in patients that appear to 48 
Page 2 of 25Journal of Veterinary Emergency and Critical Care
For Peer Review
4 
 
have adequate macrohemodynamic markers of systemic perfusion
4
.  Reduced splanchnic blood flow also 49 
increases the risk of reperfusion injury caused by oxygen free radicals if blood flow is restored after 50 
appropriate resuscitation
5
.  Local or systemic production of pro-inflammatory cytokines such as tumour 51 
necrosis factor alpha and interleukins 1 and 8 causes further alterations in perfusion of the gastric mucosa 52 
and disrupts the production of mucus and bicarbonate
6
, which are required for neutralization of gastric 53 
acid.  If the GMB is sufficiently disrupted by these changes, gastric acid may cause direct damage to the 54 
mucosa, and this process can progress to cause substantial ulceration and hemorrhage.     55 
 56 
Several factors have been identified in human patients that increase the risk of development of 57 
SRMD
2
, particularly respiratory failure necessitating mechanical ventilation and coagulopathy.  58 
Administration of prophylactic gastro-protectant medications reduces the risk of SRMD
2
, but this may be 59 
associated with development of other complications, such as aspiration pneumonia, because increased 60 
gastric pH permits bacterial colonization of the stomach
13
.       61 
 62 
Hemorrhagic GI disease has not been described specifically in veterinary ICUs, but two studies 63 
identified subclinical gastric erosions in dogs that underwent decompressive surgery for intervertebral 64 
disc disease, some of which also received glucocorticoids
7,8
.  These lesions did not appear to be 65 
responsive to administration of gastro-protectant medications.  The pathogenesis of gastric ulceration in 66 
Alaskan sled dogs at the Iditarod race may also share some features with that of SRMD in people.  67 
Strenuous exercise in these dogs resulted in increased gastric permeability and increased frequency of 68 
gastric lesions observed by endoscopy
9,10
.  The authors of this study speculated that these changes could 69 
occur due to increased circulating glucocorticoid concentrations or diversion of cardiac output to skeletal 70 
muscle for exercise.  Two further studies described development of gastroduodenal ulceration in critically 71 
ill animals in association with various underlying causes, including hepatic disease, pancreatitis, 72 
hypoadrenocorticism, and administration of non-steroidal anti-inflammatory drugs (NSAIDs)
11,12
.   73 
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 74 
The primary aim of this study was to determine the proportion of animals that developed overt 75 
hemorrhagic GI disease in veterinary ICU patients.  It was hypothesized that this would occur at similar 76 
rates to those reported in human ICUs, and that dogs would develop the disease more frequently than cats 77 
based on previous evidence suggesting that the GI tract is not the shock organ of cats.  Secondary aims 78 
were to investigate risk factors for the development of hemorrhagic GI disease, and to determine whether 79 
development of these signs was associated with mortality during the period of hospitalization.       80 
 81 
Materials and Method 82 
Study design  A retrospective multi-center survey was conducted at three intensive care units 83 
(Centers 1, 2 and 3) located in teaching hospitals in the UK.  These units accept referral cases from 84 
veterinarians in general practice and from other specialist services within the same institutions.  Case 85 
management in each unit is supervised by board certified clinicians in emergency and critical care, 86 
internal medicine, surgery or neurology.  Entry and egress of patients from the ICUs and use of any drugs, 87 
including gastro-protectant medications, were at the discretion of the attending clinician.   88 
 89 
All cases presenting consecutively to the ICUs were considered eligible for enrolment during the 90 
period of the study if they were hospitalized for at least twenty-four hours.  Cases were excluded if they 91 
had a history of hemorrhagic GI disease in the forty-eight hours prior to hospitalization or if they 92 
developed signs within the first twenty-four hours after admission.  Cases were also excluded if they 93 
underwent surgical procedures involving the GI or upper respiratory tracts, if they presented with or 94 
developed epistaxis or hemoptysis, if they presented for management of GI disease, or if they had 95 
sustained one or more skull fractures.  Cases were not excluded if they received gastro-protectant drugs, 96 
NSAIDs, glucocorticoids or anticoagulants prior to admission or during hospitalization, nor if they were 97 
diagnosed with diseases that may cause secondary GI signs, such as hypoadrenocorticism.   98 
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 99 
Data collection:  A single entry form was produced for each case enrolled in the study 100 
(Supplementary Data 1), and this was completed by a veterinarian after the patient was discharged from 101 
the ICU.  The veterinarian completing the enrolment form did not necessarily have primary responsibility 102 
for the case.  The following data were collected from the medical records of each case: signalment, 103 
presenting problem and problems identified after initial consultation, concurrent diseases and 104 
medications, clinical examination findings, GI signs observed while hospitalized, and results of complete 105 
blood cell count, serum biochemistry and coagulation profiles performed on admission.  Types of feeding 106 
tube placed in individual patients were recorded, as were the types and doses of any gastro-protectant, 107 
NSAID, glucocorticoid or antithrombotic medications administered in the ICU.  The length of 108 
hospitalization, the nature of any surgical procedures conducted immediately before or during the period 109 
of ICU hospitalization, and mortality or euthanasia while hospitalized were also noted.      110 
 111 
SRMD was defined as hemorrhagic GI disease manifesting as hematemesis, melena or 112 
hematochezia or as mucosal erosions and hemorrhage observed during GI endoscopy.  Dogs were 113 
diagnosed with systemic inflammatory response syndrome (SIRS) if they fulfilled two or more of the 114 
following four conditions:  rectal temperature <37.2C or >39.2C, heart rate >140 beats per minute, 115 
respiratory rate >30 breaths per minute, or total white blood cell count <6x10
9
/l (6,000/µl) or >19x10
9
/l 116 
(19,000/µl)
15
. 117 
 118 
Statistical analysis:  All statistical analyses were conducted using a commercial software 119 
program
a
.  Shapiro-Wilks tests and visual assessments of histograms were used to determine whether 120 
variables were parametrically distributed.  Parametric and non-parametric variables were compared using 121 
Student’s t tests and Mann-Whitney U tests, respectively.  Categorical data were compared using Fisher’s 122 
exact tests or Chi squared tests.  Confidence intervals, where stated, are at the 95% level.     123 
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 124 
The proportion of veterinary patients that developed SRMD was determined by dividing the 125 
number of cases with hematemesis, melena or hematochezia by the total number of included cases 126 
collectively and for each ICU, and 95% confidence intervals were calculated.   127 
 128 
Multivariable logistic regression was used to evaluate risk factors for development of SRMD and 129 
for mortality during hospitalization.  Univariable analyses were first conducted using Mann-Whitney U 130 
tests, Chi squared tests or Fisher’s exact tests, and variables with p values <0.2 were retained.  These 131 
variables were entered together in the multivariable analysis, and a model was fitted using a forward entry 132 
method based on calculation of likelihood ratios.  A categorical variable describing whether prophylactic 133 
gastro-protectant medications were administered was forced into the final model for development of 134 
SRMD, and a variable describing whether cases fulfilled the SIRS criteria was forced into the model of 135 
mortality as these factors were considered to be of considerable a priori importance for each model based 136 
on published evidence
2,16
.  Institute was included as a factor in both models to account for possible 137 
differences between centers.   Hosmer-Lemeshow tests were performed to assess the adequacy of model 138 
fit, and receiver operator characteristic (ROC) curves were produced using probabilities derived from 139 
each logistic regression model to determine the predictive capability of each model.     140 
 141 
Results 142 
Study populations: After removal of duplicate cases and application of exclusion criteria, 272 143 
dogs and 94 cats were included in the study (Figure 1).  Of the dogs included, 159 (58.5%) were from 144 
Center 1, 21 (7.7%) were from Center 2, and 92 (33.8%) were from Center 3.  Of the cats, 67 (71.3%) 145 
were from Center 1, 7 (7.4%) were from Center 2, and 20 (21.3%) were from Center 3.  Seventy-one dogs 146 
were intact males, 37 intact females, 82 neutered males and 82 neutered females, whereas 3 cats were 147 
intact males, 4 intact females, 51 neutered males and 36 neutered females. 148 
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 149 
  There was no difference in median age between dogs and cats, nor between animals of either 150 
species at different centers. 151 
   152 
Prevalence of GI disease:  The proportion of dogs that developed SRMD was 10.3% (CI: 6.3-153 
15.7) at Center 1, 4.8% (CI: 0.85-22.7) at Center 2 and 2.2% (CI: 0.6-7.7) at Center 3, with a combined 154 
proportion of 7.0% (CI: 4.5-10.7).  The difference in proportions between centers was not significant (Chi 155 
square 5.2, p=0.075).  SRMD did not occur in any of the cats observed during this study at any center.  156 
Among the dogs that received prophylactic gastro-protectant medications, the proportion that developed 157 
SRMD was 16.4% (CI: 8.9-28.3), compared to 4.2% (CI: 2.2-7.8) in dogs that did not receive 158 
prophylaxis, and there was a significant difference in these proportions (Chi square 10.3, p=0.001).  Rates 159 
of development of SRMD during hospitalization in dogs and cats at each center are shown in Table 2.   160 
 161 
Of the dogs that developed SRMD (n=19), the most common diagnoses were immune-mediated 162 
disease (4), neoplasia (2), trauma (2), and Angiostrongylus vasorum infestation (2).  The remaining dogs 163 
were diagnosed with pyelonephritis (1), fasciitis (1), traumatic brain injury (1), hepatic disease (1), 164 
intervertebral disc protrusion (1), hypoadrenocorticism (1), sudden acute retinal degeneration syndrome 165 
(1), sepsis and disseminated intravascular coagulation (1), and intra-abdominal hemorrhage following 166 
ovariohysterectomy (1).      167 
 168 
Feeding tubes were placed in 27 animals across all centers.  Only esophagostomy tubes were 169 
placed in cats (n=7), but naso-esophageal (n=12), esophagostomy (n=5) and gastrostomy (n=3) tubes 170 
were placed in dogs.  The majority of the tubes were placed at Center 1 (n=23), with a smaller number at 171 
Center 3 (n=4).  Placement of a feeding tube was undertaken at Center 1 after a median period of anorexia 172 
of 3 days (IQR: 3-5, range 2-9, n=13).  The duration of anorexia could not be determined in 6 dogs, and a 173 
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naso-esophageal feeding tube was placed in the remaining 4 dogs as a standard preparation for 174 
mechanical ventilation.     175 
 176 
Evaluation of risk factors for development of SRMD: Univariable analyses revealed that 177 
multiple factors were associated with development of SRMD (Table 3).  When these variables were 178 
entered into the multivariable analysis, decreased serum albumin concentration, institute and 179 
administration of prophylactic gastro-protectant medications were retained in the final model.  Dogs with 180 
SRMD were 4.3 (CI: 1.2-15.5) times more likely to have decreased serum concentrations of albumin, 4.3 181 
(CI: 1.4-13.7) times more likely to have received prophylactic gastro-protectant medications and 10.0 (CI: 182 
1.7-33.3) times less likely to have been hospitalized at Center 3 than those that did not develop SRMD.  183 
Performance of the Hosmer-Lemeshow t st indicated good model fit (Chi Square 2.2, p=0.826), and the 184 
area under the ROC curve constructed using model probabilities was 0.79 (CI: 0.68-0.90)(Supplementary 185 
Figure 1A), showing that the model was able to discriminate adequately between cases with and without 186 
SRMD.  A ROC curve was also generated using individual values for serum albumin concentration 187 
(n=201), and the area under the curve was smaller using this model (0.68, CI: 0.52-0.84)(Supplementary 188 
Figure 1B).  Using a cut-off value of 28.0 g/l (2.8 g/dl), the sensitivity and specificity values for 189 
prediction of development of SRMD were 0.67 and 0.62, respectively. 190 
 191 
Hospitalization and survival:  The median durations of hospitalization and mortality rates for 192 
dogs and cats at different centers are shown in Table 2.  There was no difference in duration of 193 
hospitalization between cats and dogs from all centers, but average length of hospitalization was greater at 194 
both Centers 2 (p=0.048) and 3 (p<0.001) compared to Center 1.  Thirty-seven (13.6%) dogs and 12 195 
(12.8%) cats died or were euthanized while hospitalized.  Mortality rates were similar between centers 196 
and species, but the proportion of dogs with SRMD that did not survive to discharge (8/19 dogs, 42.1%) 197 
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was significantly greater than for dogs that did not develop SRMD (29/252, 11.5%; Chi square 14.0, 198 
p<0.001).   199 
 200 
Evaluation of risk factors for mortality during hospitalization: Significant associations were 201 
detected between several variables and mortality during hospitalization using univariable analysis (Table 202 
4).  When these variables were entered into the multivariable analysis, placement of a feeding tube and 203 
development of SRMD were associated with mortality.  Dogs that died or were euthanized while 204 
hospitalized were 13.3 (CI: 4.0-43.5) times more likely to have had a feeding tube placed and 5.1 (CI: 205 
1.6-15.9) times more likely to have developed SRMD than those that were discharged.  Fulfilment of the 206 
SIRS criteria and institute were forced into the final model, but these variables were not significantly 207 
associated with mortality.  The model fit was adequate (Hosmer-Lemeshow Chi square 5.7, p=0.338), and 208 
generation of a ROC curve using model probabilities yielded an area under the curve of 0.77 (CI: 0.68-209 
0.86)(Supplementary Figure 2).           210 
 211 
Naso-esophageal feeding tubes were placed routinely in dogs that were mechanically ventilated.  212 
When these animals were excluded from the analysis (n=4), the odds ratio for tube placement decreased 213 
to 8.5 (CI: 2.4 – 30.3, p=0.001), while that for development of SRMD did not change considerably (OR: 214 
5.1, CI: 1.6 – 15.9, p=0.006).  Model fit parameters were similar to those reported above (data not 215 
shown).      216 
 217 
Discussion 218 
The results of this study show that hemorrhagic GI disease, defined here as SRMD, does occur in 219 
dogs hospitalized in veterinary ICUs, but was not observed in any of the cats that were included.    Dogs 220 
with SRMD were more likely to have decreased serum concentrations of albumin on presentation, but this 221 
parameter had a low sensitivity and specificity for prediction of development of this disease.  Affected 222 
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animals were also more likely to have received prophylactic gastro-protectant medications and less likely 223 
to have been hospitalized at Center 3.  SRMD and placement of a feeding tube were significantly more 224 
likely to occur in dogs that died or were euthanized while hospitalized. 225 
 226 
The proportion of dogs that developed SRMD varied considerably between Centers, and dogs at 227 
Center 3 were at significantly reduced risk compared to either Center 1 or 2.  The cause of this difference 228 
is not apparent: SRMD could have developed at similar rates at Centers 2 and 3 as at Center 1 but was not 229 
recorded, although the authors consider this scenario to be unlikely as occurrence of all forms of GI 230 
disease is considered to be a notable event among nursing staff and attending clinicians at all three 231 
centers.  The true prevalence of SRMD at Center 2 may also differ from that reported due to the small 232 
number of cases observed in this study, as indicated by the wide confidence intervals for this parameter. 233 
 234 
Measurable hemorrhage due to stress-related GI injury is reported to occur in approximately 4-235 
6% of affected humans
2,16
, which is broadly comparable to the proportion of dogs affected with SRMD 236 
defined according to this study.  In contrast to human intensive care, none of the animals included in this 237 
study underwent gastroduodenoscopy, which is a much more sensitive technique for detection of 238 
superficial erosions in the acid-secreting sections of the stomach.  When this technique was applied in 239 
dogs undergoing surgery for management of inter-vertebral disc disease, subclinical lesions were 240 
observed in approximately 75% of patients
7,8
.  The animals considered in this study are therefore likely to 241 
represent the most severely affected patients in a spectrum of stress-related GI disease, similar to the 242 
syndrome of clinically important bleeding in humans with SRMD.    243 
 244 
SRMD was not observed in any of the 94 cats that were included in this study, and this finding is 245 
consistent with the hypothesis that the GI tract is not a ‘stress organ’ in cats.  Previous experimental
17
 and 246 
epidemiologic
18,19
 studies indicate that cats are susceptible to pulmonary injury when suffering from 247 
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systemic inflammation or sepsis, and there are no previous reports suggestive of SRMD in this species.  248 
Observation of a greater number of cats in ICUs is likely to be required to determine whether SRMD 249 
occurs at lower prevalence than could be detected during this study.   250 
 251 
Dogs that developed SRMD were more likely to have decreased serum albumin concentrations at 252 
presentation.  Albumin is an essential product used in maintaining the GMB, and dogs with decreased 253 
albumin concentrations are reported to be at increased risk of dehiscence following incisional biopsy of 254 
the small intestine
20
.  It is therefore possible that dogs with hypoalbuminemia are at increased risk of 255 
SRMD and other GI signs due to their inability to maintain an effective mucosal wall.  Alternatively, the 256 
albumin concentration could be decreased in patients that have clinically undetectable GI injury resulting 257 
in increased GI permeability and prot in-losing enteropathy, prior to the onset or recognition of 258 
hemorrhagic GI disease.  Investigation of Alaskan sled dogs indicated that increased gastric permeability 259 
was an early event in development of erosive gastric disease in this cohort
10
, suggesting that 260 
hypoalbuminemia could be an effect rather than a cause of the GI signs observed.   Hypoalbuminemia in 261 
this study may also represent a non-specific marker of illness, as serum albumin is a negative acute phase 262 
protein.  Decreased serum concentrations of albumin have also been identified as negative independent 263 
prognostic factors in two studies of dogs admitted to veterinary ICUs
21,22
.   264 
 265 
With a cut off value of 28.0 g/l (2.8 g/dl, the lower limit of the reference range in use at Center 1), 266 
serum albumin concentration had a poor sensitivity and specificity for prediction of the development of 267 
SRMD, limiting the usefulness of this parameter in guiding the use of prophylactic interventions.  Further 268 
studies will be required to establish whether patients with hypoalbuminemia would benefit from 269 
administration of gastro-protectant medications.       270 
 271 
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Gastro-protectant medications were administered to a large proportion of the animals included in 272 
this study, which complicated the interpretation of the results obtained, particularly because animals that 273 
ultimately developed SRMD were more likely to have received one or more of these products.  This 274 
variable was included when fitting the logistic regression model due to its a priori importance
2
, but it 275 
would have been preferable to evaluate groups of treated and untreated dogs separately in a stratified 276 
model
23
.  This approach was not attempted in this study as the number of cases in each subgroup would 277 
have been insufficient to evaluate the number of risk factors included.       278 
 279 
Univariable analysis identified several other factors that were significantly associated with 280 
development of SRMD, including several that have previously been associated with the analogous disease 281 
in humans, such as hepatopathy, nephropathy and thrombocytopenia.  Cook and colleagues
2
 reported 282 
hepatic and renal failure as significant risk factors for development of clinically important bleeding after 283 
univariable analysis, but only secondary coagulopathy and respiratory failure necessitating mechanical 284 
ventilation were retained in the multivariable model.    Failure to identify these variables as risk factors 285 
for SRMD in this study probably relates to the relatively low prevalence of these problems in this sample, 286 
and in veterinary ICU caseloads in the UK.   287 
 288 
SRMD and placement of a feeding tube were significantly more likely to occur in dogs that died 289 
or were euthanized compared to those that were discharged.  Placement of a feeding tube is considered to 290 
be a relatively benign procedure
24
 and, in this group of patients, was usually performed at the same time 291 
as imaging or other procedures that necessitated general anesthesia or sedation.  Placement of a feeding 292 
tube in this model is more likely to be a proxy variable that could represent a prolonged history of 293 
anorexia or anticipated anorexia, or a patient likely to require a long period of intensive care following 294 
placement.  Feeding tubes were also placed in four patients in preparation for mechanical ventilation, 295 
which is also likely to be a poor prognostic indicator in veterinary ICU patients
25
.  The authors do not 296 
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consider that use of a feeding tube per se should increase the risk of death as this procedure is usually 297 
well tolerated or is associated with only minor complications
24
.  Procedures are also employed at all three 298 
centers to minimize the risk of refeeding syndrome in dogs with prolonged anorexia. 299 
 300 
Evidence from human medicine suggests that enteral nutrition should be beneficial for patients 301 
with stress-related GI disease
26
, and early re-introduction of enteral feeding may reduce the requirement 302 
for gastro-protectant medications.  A recent pilot study of dogs with pancreatitis further indicated that 303 
enteral feeding was well tolerated in critical care patients and was not associated with a greater prevalence 304 
of adverse effects compared to administration of parenteral nutrition
27
, and a study of dogs with septic 305 
peritonitis suggested that introduction of early enteral nutrition was associated with shorter duration of 306 
hospitalization
28
.  Nevertheless, it remains to be determined in future studies whether re-introduction of 307 
enteral nutrition would prevent the hemorrhagic GI disease reported in patients in this study.    308 
 309 
Development of hemorrhagic GI disease in patients that did not present for investigation or 310 
management of GI disease is likely to cause increased morbidity, either due to development of anemia, 311 
production and release of further inflammatory mediators, or increased risk of bacterial translocation 312 
across the wall of the stomach or upper small intestine.  SRMD may itself act as a proxy variable for 313 
severe systemic disease, such as SIRS, sepsis, or multiple organ dysfunction syndrome (MODS).  A 314 
variable describing fulfilment of established SIRS criteria was included in the final model of factors 315 
associated with mortality during hospitalization to try to account for this possibility as this factor was 316 
shown to be significant in a previous study
15
.  Despite this, development of SRMD remained an 317 
independent predictor of mortality, and the higher risk of mortality among patients that developed SRMD 318 
is consistent with findings in humans with overt clinical hemorrhage due to GI disease
2
. 319 
 320 
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Limitations:  Limitations of this study include the relatively small number of cases included, 321 
especially for investigation of risk factors for development of SRMD and mortality.  Animals with SRMD 322 
were more likely to have been hospitalized at Centers 1 and 2 than Center 3, and, although institution was 323 
included as an independent factor in all multivariable analyses, it is possible that unmeasured differences 324 
between centers could have acted as confounding or modifying factors.   325 
 326 
Although much of the data included in this study was collected prospectively, some information 327 
regarding development of GI disease was collected retrospectively from clinical records, reducing the 328 
reliability and consistency of these findings.  Data were also collected by a number of different 329 
investigators who may not have been involved in the primary care of the case. 330 
 331 
Conclusions:  SRMD was observed in dogs from three different veterinary ICUs but was not 332 
observed in cats.  Decreased serum albumin concentration was associated with development of SRMD, 333 
but, using a clinically relevant cut off value, this variable had a poor sensitivity and specificity for 334 
prediction of the disease.  Development of SRMD and placement of a feeding tube were independently 335 
associated with increased mortality while hospitalized, but further studies will be required to determine 336 
the effects and potential benefits of prophylactic gastro-protectant therapy in veterinary ICU patients. 337 
 338 
Footnotes 339 
a
 IBM Corp. Released 2011. IBM SPSS Statistics for Windows, Version 20.0.  Armonk, NY: IBM Corp. 340 
 341 
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Figure 1: Flow diagram of cases included in study 409 
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Supplementary Figure 1: Receiver operator characteristic curves generated using (A) probabilities from 411 
the multivariable regression model of risk factors for development of SRMD and (B) serum 412 
concentrations of albumin 413 
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Supplementary Figure 2: Receiver operator characteristic curve generated using probabilities derived 415 
from multivariable logistic regression model of risk factors for mortality during hospitalization 416 
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Table 1: Summary of demographic data obtained from included patients 
 Center 1 Center 2 Center 3 Combined 
Canine Feline Canine Feline Canine Feline Canine Feline 
N 159 67 21 7 92 20 272 94 
Time period October 2012 
to July 2013 
September to 
November 
2012 
January 2013 to 
April 2013 
  
Age (years) Median 5.9  6.9  4.8  5.0  5.0  8.5  5.1  7.2  
 Inter-
quartile 
range 
2.6 – 
9.4 
2.3 – 
12.3 
2.8 – 
6.0 
0.8 – 
10.0 
3.0 – 
8.0 
4.0 – 
12.0 
2.8 – 9.0 2.9 – 
12.0 
 
*Inter-quartile range 
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Table 2: Summary of clinical and gastro-intestinal disease data obtained from cases 
 Canine Feline 
Cente
r 1 
Cente
r 2 
Cente
r 3 
Combine
d 
Cente
r 1 
Cente
r 2 
Cente
r 3 
Combine
d 
N  159 21 92 272 67 7 20 94 
SRMD* (%)  16 
(10.3
) 
1 
(4.8) 
2 
(2.2) 
19 (7.0) 0 0 0 0 
 Melena or 
hematochezia 
(%) 
15 
(9.4) 
1 
(4.8) 
2 
(2.2) 
18 (6.6)     
 Hematemesis 
(%) 
1 
(0.6) 
0 0 1 (0.4)     
 Hemorrhage 
observed on 
endoscopy 
(%) 
0 0 0 0     
 Died/euthaniz
ed while 
hospitalized 
(% of SRMD 
cases) 
7 
(43.8
) 
0 1 
(50.0
) 
8 (42.1)     
Duration of 
hospitalization 
(days) 
Median 3.0 4.0 2.0 3.0 2.0 4.0 6.0 3.0 
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 Inter-quartile 
range 
2.0 – 
4.0 
2.0 – 
7.5 
4.0 – 
6.0 
2.0 – 5.0 2.0 – 
4.0 
1.0 – 
8.0 
2.25 
– 
8.75 
2.0 – 
5.25 
Died/euthanzi
ed while 
hospitalized 
(%) 
 27 
(17.0
) 
1 
(4.8) 
9 
(9.8) 
37 (13.6) 4 
(6.0) 
1 
(14.3
) 
7 
(35.0
) 
12 (12.8) 
Received GI§ 
prophylaxis 
(%) 
 28 
(17.6
) 
9 
(42.9
) 
19 
(20.7
) 
56 (20.6) 1 
(1.5) 
3 
(42.9
) 
1 
(5.0) 
5 (5.3) 
 Subsequently 
developed 
SRMD* (% of 
those 
receiving 
prophylaxis) 
6 
(21.4
) 
1 
(11.1
) 
2 
(10.5
) 
9 (16.1) 0 0 0 0 
 
*SRMD: Stress-related mucosal disease, §GI: gastro-intestinal 
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Table 3: Results of univariable and multivariable analysis of risk factors for development of SRMD 
 Univariable factors Multivariable model** 
Developed 
SRMD
¶
 
(%) 
Did not 
develop 
SRMD
¶
 
(%) 
p value Odds 
ratio 
95% 
Confidence 
interval 
p 
value 
Median age (years)(interquartile 
range) 
8.0 (5.0 – 
11.3) 
5.0 (2.6 
– 8.5) 
0.007 
(Mann-
Whitney U 
test) 
   
Institute Center 1 16 (5.9) 143 
(52.8) 
0.059 1.0   
 Center 2 1 (0.4) 20  
(7.4) 
 0.3 0.03 – 2.8 0.304 
 Center 3 2 (0.7) 89 
(32.8) 
 0.1 0.03 – 0.6 0.012 
Packed cell volume < 35% 12 (4.4) 72 
(26.6) 
0.003    
 ≥ 35% 7 (2.6) 180 
(66.4) 
    
Platelet count < lower 
RL§ 
6 (3.0) 30 
(15.0) 
0.045    
 ≥ lower RL 10 (5.0) 154 
(77.0) 
    
Serum albumin 
concentration 
< lower RL 11 (5.5) 94 
(46.8) 
0.110 4.3 1.2 – 15.5 0.026 
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 ≥ lower RL 4 (2.0) 92 
(45.8) 
    
Serum ALT* 
activity 
≤ 4 x upper 
RL 
11 (5.7) 168 
(86.6) 
0.019    
 > 4 x upper 
RL 
4 (2.1) 11 (5.7)     
Serum creatinine 
concentration 
≤ 2 x upper 
RL 
15 (6.8) 194 
(88.6) 
0.176    
 > 2 x upper 
RL 
2 (0.9) 8 (3.7)     
SIRSП No 5 (2.7) 85 
(45.2) 
0.086    
 Yes 13 (6.9) 85 
(45.2) 
    
Prophylactic 
administration of 
gastro-protectant 
drugs 
No 10 (3.7) 206 
(76.0) 
0.002 4.3 1.4 – 13.7 0.013 
 Yes 9 (3.3) 46 
(17.0) 
    
*ALT: alanine aminotransferase, 
§
RL: reference limit, 
П
SIRS: systemic inflammatory response 
syndrome, 
¶
SRMD: stress-related mucosal disease.  **n=201. 
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Table 4: Results of univariable and multivariable analysis of risk factors for death while hospitalized 
 Univariable factors Multivariable model¶ 
Died 
(%) 
Survived 
(%) 
p value Odds 
ratio 
95% 
confidence 
interval 
p 
value 
Median age (years)(interquartile 
range) 
7.5 
(4.0 – 
10.5) 
5.0 (2.6 
– 8.4) 
0.037 
(Mann-
Whitney 
U test) 
   
Institute Center 1 27 
(9.9) 
132 
(48.5) 
0.130 1.0   
 Center 2 1 
(0.4) 
20 (7.4)  1.3 0.2-11.3 0.808 
 Center 3 9 
(3.3) 
83 
(30.5) 
 0.9 0.3-2.8 0.836 
Packed cell 
volume 
< 35% 18 
(6.6) 
66 
(24.3) 
0.012    
 ≥ 35% 19 
(7.0) 
169 
(62.1) 
    
Platelet count < lower RL* 8 
(4.0) 
28 
(13.9) 
0.187    
 ≥ lower RL 21 
(10.4) 
144 
(71.6) 
    
Serum creatinine 
concentration 
≤ 2 x upper RL 26 
(11.8) 
184 
(83.6) 
0.006    
 > 2 x upper RL 5 5 (2.3)     
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(2.3) 
SIRS
§
 No 8 
(4.2) 
82 
(43.4) 
0.016 2.0 0.8-5.2 0.164 
 Yes 22 
(11.6) 
77 
(40.7) 
    
SRMD
П
 No 29 
(10.7) 
223 
(82.3) 
0.001 5.1 1.6-15.9 0.006 
 Yes 8 
(3.0) 
11 (4.1)     
Placement of 
feeding tube 
None 26 
(9.6) 
226 
(83.1) 
<0.001 13.3 4.0-43.5 <0.001 
 Naso-
esophageal 
7 
(2.6) 
5 (1.8)     
 Esophagostomy 2 
(0.7) 
3 (1.1)     
 Gastrostomy 2 
(0.7) 
1 (0.4)     
Mechanically 
ventilated 
No 34 
(12.5) 
233 
(85.7) 
0.019    
 Yes 3 
(1.1) 
2 (0.7)     
*RL: reference limit, §SIRS: systemic inflammatory response syndrome, ПSRMD: stress-related 
mucosal disease.  
¶
n=188. 
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